Elliot Merritt

Elliot Merritt

Auto-generated profile, based on publicly available information

Elliot Merritt

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
GWGavin Whitehouse
Gavin Whitehouse
EGElizabeth Gray
Elizabeth Gray
SMSotiris Mastoridis
Sotiris Mastoridis
EMElliot Merritt
Elliot Merritt
EKElisavet Kodela
Elisavet Kodela
MMMarc Martinez-Llordella
Marc Martinez-Llordella
CD4+CD25+FOXP3+ Tregs constitute a heterogeneous lymphocyte subpopulation essential for curtailing effector T cells and establishing peripheral tolerance. Calcineurin inhibitors (CNIs) are among the most effective agents in controlling effector T-cell responses in humans. However, CNIs also reduce the size of the Treg pool. The functional consequences of this negative effect and the mechanisms responsible remain to be elucidated. We report here that CNIs compromise the overall Treg immunoregulatory capacity to a greater extent than would be predicted by the reduction in the size of the Treg compartment, given that they selectively promote the apoptosis of the resting and activated Treg subsets that are known to display the most powerful suppressive function. These effects are caused by reduced access to IL-2, because Tregs remain capable of translocating NFAT even in the presence of high CNI levels. Exogenous IL-2 restores the phenotypic changes and overall gene-expression effects exerted by CNIs and can even promote Treg expansion by enhancing antiapoptotic Bcl-2 expression. In a skin transplant model, the addition of IL-2 synergizes with CNIs treatment, promoting intragraft accumulation of Tregs and prolonged allograft survival. Hence, the combination of IL-2 and CNIs constitutes an optimal immunomodulatory regimen that enhances the pool of suppressive Treg subsets while effectively controlling cytopathic T cells.

3 July 2024 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
BGBruno Giotti
Bruno Giotti
KDKomal Dolasia
Komal Dolasia
WZWilliam Zhao
William Zhao
PCPeiwen Cai
Peiwen Cai
RSRobert Sweeney
Robert Sweeney
ATAlexander M. Tsankov
Alexander M. Tsankov
Immunotherapies have shown great promise in pleural mesothelioma (PM), yet most patients still do not achieve significant clinical response, highlighting the importance of improving the understanding of the tumor microenvironment (TME). Here, we utilized high-throughput, single-cell RNA sequencing (scRNA-seq) to de novo identify 54 expression programs and construct a comprehensive cellular catalog of the PM TME. We found four cancer-intrinsic programs associated with poor disease outcome and a novel fetal-like, endothelial cell population that likely responds to VEGF signaling and promotes angiogenesis. Across cellular compartments, we observe substantial difference in the TME associated with a cancer-intrinsic sarcomatoid signature, including enrichment in fetal-like endothelial cells, CXCL9+ macrophages, and cytotoxic, exhausted, and regulatory T cells, which we validated using imaging and bulk deconvolution analyses on independent cohorts. Finally, we show, both computationally and experimentally, that NKG2A:HLA-E interaction between NK and tumor cells represents an important new therapeutic axis in PM, especially for epithelioid cases. Significance: This manuscript presents the first single-cell RNA sequencing atlas of PM tumor microenvironment. Findings of translational relevance, validated experimentally and using independent bulk cohorts, include identification of gene programs predictive of survival, a fetal-like endothelial cell population, and NKG2A blockade as a promising new immunotherapeutic intervention in PM.

1 April 2017 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
KCKate Childs
Kate Childs
EMElliot Merritt
Elliot Merritt
ACAisling Considine
Aisling Considine
ASAlberto Sanchez-Fueyo
Alberto Sanchez-Fueyo
KAKosh Agarwal
Kosh Agarwal
ICIvana Carey
Ivana Carey
Sustained virological response rates (SVRs) to directly acting antiviral (DAA) therapy for hepatitis C virus (HCV) are lower in decompensated cirrhosis. Markers of innate immunity predict nonresponse to interferon-based HCV treatment; however, whether they are associated with the response to DAAs in patients with decompensation is not known. Information on demographics, adherence, viral kinetics, and resistance were gathered prospectively from a cohort with decompensated cirrhosis treated with 12 weeks of DAAs. C-X-C motif chemokine-10 (CXCL-10) level and T-cell and natural killer (NK) cell phenotype were analyzed pretreatment and at 4 and 12 weeks of treatment. Of 32 patients, 24 of 32 (75%) achieved SVR (responders). Eight of 32 (25%) experienced relapse after the end of treatment (nonresponders). There were no differences in demographics or adherence between groups. Nonresponders had higher CXCL-10; 320 pg/mL (179461) vs 109 pg/mL (88170) in responders (P < .001) and differential CXCL-10 dynamics. Nonresponders had lower NK cell frequency, higher expression of activation receptor NKp30, and lower frequency of the NK subset CD56−CD16+. Nonresponders to DAAs displayed a different NK phenotype and CXCL-10 profile to responders. Nonresponders did not have poorer adherence or baseline virological resistance, and this shows that immunological parameters are associated with treatment response to interferon-free treatment for HCV in individuals with decompensated cirrhosis.

10 June 2020 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
EMElliot Merritt
Elliot Merritt
MLMaria Carlota Londono
Maria Carlota Londono
KCKate Childs
Kate Childs
GWGavin Whitehouse
Gavin Whitehouse
EKElisavet Kodela
Elisavet Kodela
MMMarc Martínez-Llordella
Marc Martínez-Llordella
Virus‐induced heterologous immunity is considered a barrier to transplantation tolerance. Yet, hepatitis C (HCV)‐infected liver transplant (LT) patients occasionally achieve operational tolerance. We investigated the mechanisms through which HCV infection modulates donor‐specific T cell responses following LT and the influence of HCV eradication. We generated T cell lines from HCV‐infected LT and non‐LT patients before and after HCV eradication and quantified alloreactive responses using cell lines expressing single‐HLA class‐I antigens in the presence/absence of PD‐1/CTLA‐4 blockade. HCV‐specific CD8+ T cells cross‐reacted with allogeneic class‐I HLA molecules. HCV‐positive LT recipients exhibited a higher proportion of CD8+ T cells coexpressing inhibitory receptors (PD‐1/CTLA4) than HCV‐negative LT, and their expression correlated with CXCL10 plasma levels. This resulted in decreased antidonor and third‐party proliferative responses, which were significantly reversed by HCV eradication. PD‐1/CTLA‐4 blockade increased the proportion of HCV‐specific CD8+ T cells reacting against donor only before viral clearance. In conclusion, HCV infection results in the generation of HCV‐specific CD8+ T cells capable of reacting against allogeneic HLA molecules. Following LT, this results in a PD‐1/CTLA4‐dependent decrease in alloimmune responses. Our findings challenge the notion that heterologous immunity is necessarily detrimental in LT and provide an explanation for the association between HCV eradication and immune‐mediated allograft damage.

17 June 2026
Verified
Other
Open access
BGBruno Giotti
Bruno Giotti
KDKomal Dolasia
Komal Dolasia
WZWilliam Zhao
William Zhao
PCPeiwen Cai
Peiwen Cai
RSRobert Sweeney
Robert Sweeney
ATAlexander M. Tsankov
Alexander M. Tsankov
Macrophages in scS-high PM express CXCL9/10/11 and likely contribute to T-cell infiltration

17 June 2026
Verified
Other
Open access
BGBruno Giotti
Bruno Giotti
KDKomal Dolasia
Komal Dolasia
WZWilliam Zhao
William Zhao
PCPeiwen Cai
Peiwen Cai
RSRobert Sweeney
Robert Sweeney
ATAlexander M. Tsankov
Alexander M. Tsankov
Molecular dissection of T cell programs and IC molecules shows association with scS-score